Our Partners

BIOASTER
European Clinical Research Infrastructure Network (ECRIN)
Fraunhofer Institute for Molecular Biology and Applied Ecology IME
IDMIT Infrastructure (CEA)
Institute for Translational Vaccinology (ITV)
Leiden University (LU)
Public Health England (PHE)
The National Institute for Biological Standards and Control (NIBSC)
Vaccine Formulation Institute (VFI)
Biomedical Primate Research Centre (BPRC)
European Infrastructure for Translational Medicine (EATRIS)
GenIbet Biopharmaceuticals
Institut de Recerca i Tecnologia Agroalimentàries (IRTA)
Instituto de Biologia Experimental e Tecnológica (iBET)
Leiden University Medical Center, Dept. Infectious Diseases
Sclavo Vaccine Association (SVA)
University of Oxford
Wageningen Bioveterinary Research, Wageningen University & Research (SWR)
ETH Zürich
European Vaccine Initiative (EVI)
Helmholtz Centre for Infection Research (HZI)
Institut national de la Recherche agronomique (INRA)
Instruct Academic Services Limited
London School of Hygiene and Tropical Medicine (LSHTM)
Statens Serum Institut (SSI)
University of Siena (UNISI)

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative